These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7083183)

  • 1. Introduction to the conference, Aromatase: New Perspectives for Breast Cancer.
    Santen RJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3268s. PubMed ID: 7083183
    [No Abstract]   [Full Text] [Related]  

  • 2. Closing remarks to the conference, Aromatase: New Perspectives for Breast Cancer.
    Lipton A; Harvey HA; Santen RJ
    Cancer Res; 1982 Aug; 42(8 Suppl):3468s. PubMed ID: 7083210
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor.
    Santen RJ; Santner SJ; Tilsen-Mallett N; Rosen HR; Samojlik E; Veldhuis JD
    Cancer Res; 1982 Aug; 42(8 Suppl):3353s-3359s. PubMed ID: 7083200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aminoglutethimide--a new endocrine therapy in breast cancer. A cancer research review.
    Harris AL
    Exp Cell Biol; 1985; 53(1):1-8. PubMed ID: 3881300
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aromatase inhibitor].
    Stein M
    Med Monatsschr Pharm; 1993 Mar; 16(3):66-7. PubMed ID: 8464387
    [No Abstract]   [Full Text] [Related]  

  • 6. Adequacy of estrogen suppression with aminoglutethimide and hydrocortisone as treatment of human breast cancer: correlation of hormonal data with clinical responses.
    Santen RJ; Worgul TJ; Samojlik E; Boucher AE; Lipton A; Harvey H
    Cancer Res; 1982 Aug; 42(8 Suppl):3397s-3401s. PubMed ID: 7083205
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of estrogen antagonists and aromatase inhibitors in breast cancer and hormonally sensitive tumors of the uterine body.
    Gadducci A; Cosio S; Genazzani AR
    Curr Opin Investig Drugs; 2004 Oct; 5(10):1031-44. PubMed ID: 15535424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-hormonal therapy in breast cancer].
    Ecker-Schlipf B
    Med Monatsschr Pharm; 1994 Aug; 17(8):247-50. PubMed ID: 7935152
    [No Abstract]   [Full Text] [Related]  

  • 9. Induction of aromatase expression by aminoglutethimide, an aromatase inhibitor that is used to treat breast cancer in postmenopausal women.
    Kao YC; Okubo T; Sun XZ; Chen S
    Anticancer Res; 1999; 19(3A):2049-56. PubMed ID: 10470147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeutic results obtained with aminoglutethimide in advanced-stage breast cancer. Factors predictive of a response].
    Paridaens RJ; Arrigo C; Heuson JC
    Acta Clin Belg Suppl; 1986; 11():18-28. PubMed ID: 3459320
    [No Abstract]   [Full Text] [Related]  

  • 11. Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.
    Nicholson RI; Walker KJ; Davies P
    Cancer Surv; 1986; 5(3):463-86. PubMed ID: 3555778
    [No Abstract]   [Full Text] [Related]  

  • 12. Interactions of antioestrogens and aromatase inhibitors.
    Schmid P; Possinger K
    Forum (Genova); 2002; 12(1):45-59. PubMed ID: 12634910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conference on aromatase: new perspectives for breast cancer. Key Biscayne, Florida/Dec 6-9, 1981.
    Cancer Res; 1982 Aug; 42(8 Suppl):3263s-3469s. PubMed ID: 7083182
    [No Abstract]   [Full Text] [Related]  

  • 14. Anastrozole ('Arimidex') blocks oestrogen synthesis both peripherally and within the breast in postmenopausal women with large operable breast cancer.
    Miller WR; Stuart M; Sahmoud T; Dixon JM
    Br J Cancer; 2002 Oct; 87(9):950-5. PubMed ID: 12434282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steroid hormone profiles in women treated with aminoglutethimide for metastatic carcinoma of the breast.
    Samojlik E; Santen RJ; Kirschner MA; Ertel NH
    Cancer Res; 1982 Aug; 42(8 Suppl):3349s-3352s. PubMed ID: 7083199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aromatase in the context of breast and endometrial cancer. A review.
    Jongen VH; Hollema H; Van Der Zee AG; Heineman MJ
    Minerva Endocrinol; 2006 Mar; 31(1):47-60. PubMed ID: 16498363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aromatase inhibitors: new endocrine treatment of breast cancer.
    Brueggemeier RW
    Semin Reprod Med; 2004 Feb; 22(1):31-43. PubMed ID: 15083379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aromatase inhibitors--new possibilities in treatment of breast carcinoma].
    Friedrichs K; Jänicke F
    Praxis (Bern 1994); 1998 Apr; 87(17):584-8. PubMed ID: 9623325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of breast tumour aromatase activity and response to aromatase inhibition with aminoglutethimide.
    Bezwoda WR; Mansoor N; Dansey R
    Oncology; 1987; 44(6):345-9. PubMed ID: 3684175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.